The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Sarepta Therapeutics Inc shares valued at $822,100 were sold by Estepan Ian Michael on Aug 30 ’24. At $137.36 per share, Estepan Ian Michael sold 5,985 shares. The insider’s holdings dropped to 33,946 shares worth approximately $4.34 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Estepan Ian Michael purchased 5,985 shares, netting a total of over 822,130 in proceeds.
Before that, Chambers Michael Andrew had added 37,038 shares to its account. In a trade valued at $4,955,728, the Director bought Sarepta Therapeutics Inc shares for $133.80 each. Upon closing the transaction, the insider’s holdings increased to 37,038 shares, worth approximately $36.29 million.
As published in their initiating research note from Jefferies on October 21, 2024, Sarepta Therapeutics Inc [SRPT] has been a Buy and the price target has been revised to $165. As of July 29, 2024, RBC Capital Mkts has increased its “Sector perform” rating to a “an Outperform” for SRPT. Earlier on June 26, 2024, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for SRPT stock which previously was a “a Buy”.
Analyzing SRPT Stock Performance
During the last five days, there has been a drop of approximately -1.62%. Over the course of the year, Sarepta Therapeutics Inc shares have jumped approximately 32.51%. Shares of the company reached a 52-week high of $173.25 on 06/21/24 and a 52-week low of $91.34 on 01/05/24. A 50-day SMA is recorded $128.23, while a 200-day SMA reached $130.45. Nevertheless, trading volume fell to 0.66 million shares from 0.43 million shares the previous day.
Support And Resistance Levels for Sarepta Therapeutics Inc (SRPT)
According to the 24-hour chart, there is a support level at 126.50, which, if violated, would cause prices to drop to 125.22. In the upper region, resistance lies at 129.96. The next price resistance is at 132.13. RSI (Relative Strength Index) is 51.60 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.78, which suggests the price will increase in the coming days. Percent R is at 49.87%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
